TotalMarketCap

Addex Therapeutics

ADXNNasdaq SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.856 M

$2.85 -4.04%

Close of 6 Nov 2026

As of 6 Nov 2026, Addex Therapeutics (ADXN) has a market capitalization of $4.86M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

147,831,814

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #451GelteqGELS$4.88M
  2. #452ImunonIMNN$4.86M
  3. #453Addex TherapeuticsADXN$4.86M
  4. #454Can-Fite BioPharmaCANF$4.85M
  5. #455Skye BioscienceSKYE$4.65M

What if Addex Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$16,573,728

Per share 5,815,139× higher

Bitcoin $1.53T

$896,775.58

Per share 314,647× higher

Apple $5.02T

$2,944,031

Per share 1,032,957× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Addex Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.